ONC201 in combination with carboplatin and etoposide as a novel triple drug treatment for small cell lung cancer (SCLC)

被引：0
|
作者：
Lee, Young S. [1 ]
Zhou, Lanlan [1 ]
Azzoli, Christopher [1 ]
El-Deiry, Wafik S. [1 ]
机构：
[1] Brown Univ, Providence, RI 02912 USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4056
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Carboplatin (C) and etoposide (E) in previously untreated extensive stage small cell lung cancer (ED-SCLC)
    Yilmaz, U.
    Halilcolar, H.
    Yildirim, Y.
    Yapicioglu, S.
    Unsal, I.
    Kuzer, P.
    Altiparmak, O.
    Cinar, T.
    LUNG CANCER, 2006, 52 : S43 - S43
  • [32] Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study
    Kakolyris, S
    Mavroudis, D
    Tsavaris, N
    Souglakos, J
    Tsiafaki, P
    Kalbakis, K
    Agelaki, S
    Androulakis, N
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2001, 12 (02) : 193 - 197
  • [33] Antitumor efficacy of combination treatment with ONC201 and enzalutamide or darolutamide in metastatic castration-resistant prostate cancer
    Wu, Jinxuan Laura
    Zhou, Lanlan
    Zhang, Leiqing
    Huntington, Kelsey E.
    Carneiro, Benedito
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2022, 82 (12)
  • [34] ONC201 synergistically induces cell death in triple negative breast cancer with CDK 4/6 and MEK inhibition
    Lim, Bora
    Peterson, Christine
    Cho, Elin
    Davis, Alexander
    Pearson, Troy
    Liu, Huey
    Hwang, Minha
    Tripathy, Debu
    Ueno, Naoto T.
    Lee, Jangsoon
    CANCER RESEARCH, 2020, 80 (04)
  • [35] Atezolizumab in combination with carboplatin and etoposide (CE) for small-cell lung cancer after failure to CE
    Takeda, Takayuki
    Kataoka, Nobutaka
    Kunimatsu, Yusuke
    Tachibana, Yusuke
    Sugimoto, Takumi
    Sato, Izumi
    Tani, Nozomi
    Ogura, Yuri
    Hirose, Kazuki
    ANNALS OF ONCOLOGY, 2021, 32 : S356 - S356
  • [36] Phase I/II study of combination chemotherapy with cisplatin, carboplatin and etoposide in small cell lung cancer
    Sakurai, M
    Ichiki, M
    Hayashi, I
    LUNG CANCER, 1996, 15 (02) : 225 - 232
  • [37] COMBINATION CYCLOPHOSPHAMIDE AND ETOPOSIDE IN TREATMENT OF SMALL-CELL LUNG-CANCER
    LEUNG, WT
    SHIU, WCT
    PANG, JCK
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1990, 7 (01): : 31 - 34
  • [38] CISPLATIN AND CARBOPLATIN IN COMBINATION WITH ETOPOSIDE AS A TREATMENT FOR NON-SMALL CELL LUNG-CANCER - THE EXPERIENCE OF THE EORTC LUNG-CANCER WORKING PARTY
    KLASTERSKY, J
    CANCER TREATMENT REVIEWS, 1988, 15 : 33 - 40
  • [39] STUDY15: a multicentre, randomised trial comparing combination gemcitabine/carboplatin and hydroxychloroquine versus carboplatin/etoposide therapy for stage IV small-cell lung cancer (SCLC)
    Ngai, Y.
    Hackshaw, A.
    Blackhall, F.
    Greystoke, A.
    Ahmed, S.
    El-Khouly, F.
    Farrelly, L.
    Jenner, R.
    Bremner, F.
    Salomoni, P.
    Hewish, M.
    Morriss, E.
    Lee, S. M.
    LUNG CANCER, 2018, 115 : S84 - S84
  • [40] Carboplatin plus etoposide or topotecan for small-cell lung cancer
    Arrieta, Oscar
    Lara-Mejia, Luis
    Zatarain-Barron, Zyanya Lucia
    LANCET ONCOLOGY, 2020, 21 (09): : 1132 - 1134
12345